HIGHLIGHTS
- who: S. E. Boer from the Background: In, more than , % of all newly transplanted kidney transplant recipients in The Netherlands Department of Internal Medicine, Division of Nephrology, University Medical have published the paper: Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients, in the Journal: (JOURNAL)
- what: The study showed that the reducedexposure CNI regimen offered comparable efficacy and graft function, with low rates of treated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.